Viewing Study NCT06013969


Ignite Creation Date: 2025-12-24 @ 11:08 PM
Ignite Modification Date: 2026-01-02 @ 11:51 PM
Study NCT ID: NCT06013969
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-19
First Post: 2023-08-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Test Whether Spesolimab Helps People With Generalized Pustular Psoriasis (GPP) Who Need Treatment for Repeated Flares
Sponsor: Boehringer Ingelheim
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 1368-0120
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators